IQM Quantum Computers (IQMX) Reports Record Orders Despite One-Time Listing Costs

Key Takeaways

• IQM Quantum Computers reported third-quarter 2026 revenue of €8.9 million, up 51% year over year.
• The company booked a record €42.2 million in new orders, lifting its order backlog to €102.5 million, up 52% from the start of the year.
• Its largest contract to date — a €33 million order for the Halocene error-correction platform from Finland's CSC and the LUMI AI Factory — anchored the quarter's bookings.
• Net loss widened to €152.6 million, driven mainly by a €127.1 million one-time share-listing expense tied to the July Nasdaq debut.
• Management reaffirmed full-year 2026 guidance of €42 million to €47 million in revenue and €65 million to €75 million in order intake.
• Cash and cash equivalents stood at €260.4 million as of September 30, 2026, supporting ongoing investment in deliveries and fabrication capacity.

Understanding the Quarter's Context

IQM Quantum Computers, the first European quantum computing company listed on a major U.S. exchange, only began trading on the Nasdaq Global Select Market in July 2026 under the ticker IQMX. As a result, this third-quarter report offers one of the first public windows into how the company's full-stack superconducting quantum computing business is scaling. Investors are watching order intake and backlog closely, because hardware deliveries are milestone-driven and revenue can shift between quarters based on customer acceptance timing. The quarter's record bookings signal rising demand from supercomputing centers, national laboratories, and AI infrastructure projects, while the widening net loss reflects the heavy investment and one-time listing costs inherent in an early-stage deep-tech company. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Breaking Down the Numbers

For the third quarter of 2026, IQM Quantum Computers reported revenue of €8.9 million, up 51% from €5.9 million in the prior-year period. Revenue for the first nine months of 2026 grew 49% year over year to €17.7 million, entirely from commercial contracts with no public funding or grants included. Gross margin was 47% in the quarter, a slight improvement from 46% in the second quarter.

Commercial momentum was the standout metric. The company booked €42.2 million in new order intake during Q3, bringing year-to-date intake to €52.9 million. This lifted the order backlog to €102.5 million as of September 30, 2026, up 52% from the beginning of the year. The quarter's largest win was a €33 million contract from CSC's LUMI AI Factory for the Halocene error-correction platform, roughly equivalent in value to the company's entire 2025 revenue.

On the bottom line, the net loss for the quarter widened to €152.6 million, compared with €12.6 million a year earlier. The increase was driven primarily by a €127.1 million one-time share-listing expense related to the company's July Nasdaq listing, along with higher research, administrative, and selling costs. Basic loss per share was €0.81, versus €0.41 in the prior-year quarter. Management reiterated its full-year 2026 outlook.

Market Reaction and Investor Sentiment

Shares of IQMX fell sharply on the day results were released, reflecting a mixed interpretation of the quarter. While the record order intake and 51% revenue growth underscored strong commercial traction, investors appeared to weigh the larger-than-expected net loss and the one-time listing charge against the headline figures. The concentration of revenue recognition in the fourth quarter, tied to delivery and customer acceptance of 150-qubit systems, also added a note of caution. Sentiment around quantum computing names remains volatile, with the market balancing long-term technology potential against near-term profitability and cash-burn concerns.

Forward Outlook and Key Factors to Monitor

Looking ahead, management's reaffirmed guidance places significant emphasis on fourth-quarter execution. IQM expects roughly €20 million to €25 million of revenue to be recognized in the final quarter, driven largely by delivery and customer acceptance of its 150-qubit systems. Because standardized systems are recognized upon acceptance — a process that depends on site readiness, cooling and power infrastructure, and procurement sign-offs — the timing of those deliveries is a key swing factor for the full-year result.

Beyond the quarter, investors will likely monitor whether the record backlog converts into revenue at the expected pace. The €33 million LUMI-IQ Halocene order is structured as a multi-year, staged delivery, beginning with an H4 system in 2027 and scaling toward error-corrected systems by 2029. This roadmap makes order intake and backlog the clearest leading indicators of future growth.

Other factors worth watching include cash consumption as the company invests in fabrication and assembly capacity, the pace of new customer wins across its four operating continents, and progress toward its first error-correction demonstrators targeted for 2027. As with other early-stage hardware businesses, the balance between commercial momentum and ongoing operating losses will remain central to how investors assess the stock.

Exploring AI Tools in My Research Process

In my analysis of emerging names like IQMX, I often turn to Tickeron's AI Screener to quickly compare fundamentals, technical patterns, and industry peers. It helps surface relevant data points without manual effort and supports a more structured view of opportunities in the quantum computing space.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Contributor

Sergey Savastiouk|Expert

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.

Notable companies

Industry description

Market Cap

High and low price notable news

Volume